Michael Kaseta

Michael Kaseta

DirectoratLiquidia· In proxies 2022–2025

Pay in FY2025+10% from the year before · Liquidia stock +193.3% the same year

Michael Kaseta was paid $4.2M in FY2025 (Dec), up 10%. Liquidia stock rose 193.3% that year.

Pay$100 in the stock at the end of FY21 → $375
Pay is from the Summary Compensation Table of each Liquidia proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Heron Therapeutics, Inc. /De/Public company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  2. LiquidiaPublic company · 4 yr
    • Chief Financial Officer and Chief Operating Officer2022 – Present · 4 yrStock in role +898%

Roles come from the proxy statements of each company.

Boards1

  • Heron Therapeutics, Inc. /De/Director · 1 yr on the boardIndependentAudit, Compensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?